India Pesticides Ltd Q3 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/gselh2i1ca08v0l8ru96wf1k.pdf

Key Takeaways


Export Surge & Demand Drivers

D K Jain: "from China we have not so much of competition at all because the manufacturers of these compounds in China are relatively very small."

Margin Dynamics & Cost Pressures

D K Jain: "Sir actually the ultimate usage price in the market that does not get absorbed probably that is why we are not able to pass on the complete cost increase, though we have an arrangements with the companies and the raw material cost we are able to pass on but the overall manufacturing cost and the energy cost that becomes difficult for us to pass on that is why there is some effect on us."
D K Jain: "50- 51% it will be very difficult to say but we will try our maximum whatever is possible."

New Product Engine & Capacity Build

D K Jain: "Our strategy is that way only Sir that we would like to be backward integrated company. We do very few products N minus one strategy."

Hamirpur Greenfield: The Next Leg


Guidance & Commitments

CommitmentSpecificsTimeline
High-cost inventory consumptionUtilize high-cost raw material inventory, improving marginsQ4 FY2023
Sandila capex completionBalance of ₹70 Cr FY2023 capex completedBefore March 2023
FY2024 topline"Easily" reach ~₹1,000–1,100 Cr with existing plantsFY2024
New product revenue contribution~₹250 Cr incremental turnover from new capacitiesFY2024
New product gross margins~46–47% (down from earlier 50%+ yardstick due to inflation)FY2024
Capacity utilizationFull utilization of expanded Sandila capacityEnd of FY2024
Hamirpur first units operationalFirst two units start productionDecember/January 2023–24
Hamirpur meaningful contributionSite contributes materially after stabilizationFY2025 onwards
New product launchesAt least four products: two in subsidiary, two in existing plantFY2024
Eighth molecule launchAlready under construction, launch planned soonUndated
EBITDA margin23% to 25% projectedFY2024
Inventory reductionReduce by at least ₹25 Cr from December levelBy year-end FY2023
Hamirpur annual capex run-rate~₹100 Cr per annumComing four years
S P Gupta: "EBITDA margin we are projecting next year is between 23 to 25% and since our product has very stable pricing environment the presence of China is very less so we do not see much downward risk due to price reduction but even our buyers they are not able to increase price very much so stable kind of environment we are projecting as far as pricing is concerned."

Key Metrics

MetricQ3 FY23
Total revenue₹222 cr, +16% YoY
EBITDA₹51 cr, margin of ~22%
PAT₹35 cr, vs ₹43 cr in Q3 FY22; PAT margin 15.7%
Export revenue₹148 cr, vs ₹109 cr in Q3 FY22
Domestic revenue₹69 cr, vs ₹81 cr in Q3 FY22
Technicals revenue₹184 cr
Formulations revenue₹34 cr
Export share of revenue68%, up from 49% in Q2 FY23
Volume growth (YoY)+8%, price also +8%, total revenue growth 16%
Technicals volume sold>4,000 tonnes, vs ~3,900 tonnes in Q2 FY23
Gross margin~45%, improved from ~43% QoQ; high-cost inventory still being consumed
New product contribution (quarter)~₹25 cr, vs ~₹12–13 cr in Q3 FY22
New product contribution (9M FY23)~12% of sales
Technicals utilization (9M FY23)~72%
Formulations utilization (9M FY23)~40%, impacted by channel inventory and off-season
Inventory closing value~₹225 cr, flat vs Q2 FY23; expected to reduce by at least ₹25 cr by year-end
FY24 EBITDA margin guidance23–25%
FY24 incremental revenue from new capacities~₹250 cr expected
Hamirpur capex spent till date~₹10 cr, further ₹7–10 cr expected in next two months
Sandila capex done in 9M FY23₹54 cr of the planned ₹70 cr for FY23